Navigation Links
Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
Date:10/23/2008

New drug is company's third to enter human trials in 2 years

DURHAM, N.C., Oct. 23 /PRNewswire/ -- Addrenex Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved its Investigational New Drug Application (IND) for ADX415, a novel hypertension drug. With the approval, Addrenex has launched a phase 2 clinical trial to study ADX415 as a targeted therapy for hypertension.

The phase 2 trial is a multicenter, double-blind, placebo-controlled, dose-ranging study that will involve 80 patients. ADX415 is a novel, patented, centrally acting, alpha-adrenergic receptor agonist specific to alpha-2 receptors.

ADX415 is the company's third drug to receive IND approval and enter human trials in a 2-year period, continuing the rapid pace of drug development at Addrenex. ADX415 was identified from an extensive library of alpha-2 adrenergic compounds that Addrenex licensed from the University of Nebraska Medical Center and that originated from Procter & Gamble Pharmaceuticals.

The scientific focus of Addrenex is the treatment of medical conditions that arise from an overactive or improperly regulated adrenergic system, a group of hormones produced by the adrenal glands that regulates diverse physiologic functions such as blood pressure, heart rate and response to stress.

"Numerous medical conditions arise from an overactive adrenergic nervous system, yet few drugs are available that specifically target this complex pathway," said Moise Khayrallah, cofounder and chief executive officer of Addrenex. "We built our company to address a wide range of conditions whose symptoms are not fully managed by drugs currently on the market. Our scientific team continues to identify and analyze alpha-2 compounds that could potentially address the unmet needs of patients across a wide range of conditions."

The company's first two drug candidates are Clonicel to treat attention deficit hyperactivity disorder (ADHD) an
'/>"/>

SOURCE Addrenex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
2. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... a company overview at the UBS Global Healthcare Conference in ... for Wednesday, May 22 nd at 11 a.m. Eastern ... of the presentation, please visit the Investor Relations section of ... will be available for 14 days after the event. ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- United Medical ... Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS) ... PALS, BLS and ACLS online course manuals. ... people simply need to build an account with the ... for these programs, United Medical Education is setting a ...
(Date:5/17/2013)... PONCE , Puerto Rico , May ... southern, central and western Puerto Rico , ... , PR) Center has improved its radiation therapy capabilities with ... in Puerto Rico . Versa HD offers ... wide range of tumors throughout the body, while also enabling ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... 2011 HeartWare International, Inc. (NASDAQ: HTWR ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... Doug Godshall is scheduled to present at the Lazard ... 1:55 p.m. ET on Thursday, September 22, 2011.  The ...
... Laboratory Supply Company (LABSCO), the largest privately held ... hospitals, physician office laboratories, reference labs and other non-acute ... industry veteran Rod Wolford to its board ... during an incredible time of growth and opportunity, and ...
Cached Medicine Technology:HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2Rod Wolford Joins LABSCO Board of Directors 2
(Date:5/19/2013)... Chicago, IL (PRWEB) May 19, 2013 In ... Surge, LLC, E-dentist.com has announced the launch of an SEO ... help dentists get high rankings in Google. , http://www.e-dentists.com/ ... do not pay for the service until they see results. ... sites. The lead generation websites run by JD Media Surge, ...
(Date:5/19/2013)... 19, 2013 Grinding your teeth at ... sleep, or annoying your spouse. At the same time, ... Central (“Snoring and Teeth Grinding Could Be a Sign ... grinding can be hard to prevent. Apparently, Obstructive Sleep ... one of its symptoms is a habit of teeth ...
(Date:5/19/2013)... The report “Feed Additives Market by Types, Livestock & ... published by MarketsandMarkets, defines and segments the global animal ... global volume and revenue for the animal feed additives. ... the global market with analysis of trends, opportunities, burning ... and revenue is forecasted on the basis of major ...
(Date:5/19/2013)... Farming methods have changed many times since man ... ago. Most recently, the Green Revolution has transformed farming ... seeds and by applying chemical fertilizers and pesticides. But ... due to the adverse environmental and health effects of ... interest in organic, sustainable farming practices and techniques. Enter ...
(Date:5/19/2013)... Los Angeles (PRWEB) May 19, 2013 Yeast ... infections can appear in sensitive areas of the human body. ... by Yeastrol. This new formula provides a unique method of ... This new spray solution is now provided to men and ... Yeast is naturally absorbed in the body through food and ...
Breaking Medicine News(10 mins):Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2
... the Sheikh Zayed Institute for Pediatric Surgical Innovation ... drug that has shown early promise as an option for ... fight off bacterial infections, particularly sepsis. The study, ... Anesthesiology , sheds new light on the role of ...
... ROCHESTER, Minn. -- Global Bridges, a healthcare alliance for ... regional partner, King Hussein Cancer Center (KHCC) in Amman, ... care providers in the Eastern Mediterranean Region (EMRO) on ... training, scheduled for April 27-28 at KHCC, will engage ...
... Rice University bioengineering students in collaboration with the Texas ... chances to arrhythmia victims headed toward cardiac arrest. ... seniors created a unique pad system for automated external ... heart back into a proper rhythm in an emergency. ...
... to increase despite the use of sunscreen and ... prevent melanoma lesion formation, according to Penn State ... melanoma incidence suggests that additional preventive approaches are ... Robertson, Ph.D., professor of pharmacology, pathology, dermatology and ...
... 26, 2011) A study performed by University of ... in treating Ureaplasma-colonized or infected premature infants to prevent ... Pulmonology, showed subjects colonized or infected with the Ureaplasma ... time in the azithromycin-treated group, compared to 94 percent ...
... Reporter , MONDAY, April 25 (HealthDay News) -- The ... of life for people suffering from heart failure, Harvard ... balance and weight-shifting, breathing techniques and focused internal awareness. ... a number of medical conditions, including hypertension (high blood ...
Cached Medicine News:Health News:Study: Resiniferatoxin may increase sepsis-related mortality 2Health News:Health-care alliance for tobacco dependence treatment launches training in the Middle East 2Health News:Unique AED pads give hearts a second chance 2Health News:Topical treatment may prevent melanoma 2Health News:Antibiotic may prove beneficial to preterm infant lung health 2Health News:Tai Chi May Help Heart Failure Patients 2Health News:Tai Chi May Help Heart Failure Patients 3
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medium weight bone cutter....
Micro emulsifying needles, 18G....
Rhoton bayonets scissors, straight tip....
Medicine Products: